IndyGeneUS AI
IndyGeneUS AI is a black-owned, service-disabled veteran-owned small business driving precision medicine through data mining and AI to accelerate the development and manufacturing of targeted therapies. Their mission is to address health disparities faced by African diaspora populations by improving access to high-quality, equitable healthcare. The company aims to be the #1 CDMO and a global leader in advanced targeted therapy development, leveraging their large-scale manufacturing and analytical programs. They offer a comprehensive suite of services including process development, testing and analytical services, plasmid manufacturing, scalable vector production (AAV), cell banking, and cell processing. IndyGeneUS AI also offers whole genome sequencing through its IndyGeneUS-IQ™ kits, decoding 100% of a user's DNA for ancestry, health predictions, and disease risk assessment, with a focus on privacy and blockchain security. They are seeking investors and partners interested in their work.
IndyGeneUS AI
IndyGeneUS AI is a black-owned, service-disabled veteran-owned small business driving precision medicine through data mining and AI to accelerate the development and manufacturing of targeted therapies. Their mission is to address health disparities faced by African diaspora populations by improving access to high-quality, equitable healthcare. The company aims to be the #1 CDMO and a global leader in advanced targeted therapy development, leveraging their large-scale manufacturing and analytical programs. They offer a comprehensive suite of services including process development, testing and analytical services, plasmid manufacturing, scalable vector production (AAV), cell banking, and cell processing. IndyGeneUS AI also offers whole genome sequencing through its IndyGeneUS-IQ™ kits, decoding 100% of a user's DNA for ancestry, health predictions, and disease risk assessment, with a focus on privacy and blockchain security. They are seeking investors and partners interested in their work.
TL;DR
Industry: Biotechnology / Genomics
Headquarters: Washington, D.C.
Founded: 2021 or 2022 (sources report both)
Products / Services: Whole‑genome sequencing, multi‑omic AI analytics, blockchain‑secured genomic data repository, CDMO services
Notable investors: Merck Global Health Innovation Fund; Johnson & Johnson (including Robotics & Digital Solutions); IsimoVest; Voltron Capital